"DIAGNOSIS AND TREATMENT OF ADENOVIRAL CONJUNCTIVITIS ON AN OUTPATIENT BASIS"

Abstract

Epidemic conjunctivitis (EC) is a frequent highly infectious disease of the ocular surface caused by adenovirus infection, and its epidemics cause great economic losses, including temporary disability of patients and, in some cases, loss of vision. can lead to a permanent decrease.

Тarget: Improving the efficiency of ambulatory treatment of adenoviral conjunctivitis with the inclusion of Virostav in therapy.

Materials and methods: 46 patients aged 18-57 years with adenovirus conjunctivitis (AVK) treated on an outpatient basis at RIKMIATM Bukhara branch were observed. 43 of them had adenovirus conjunctivitis, 3 had adenovirus keratoconjunctivitis. The most important thing is the effectiveness of the drug under consideration in the treatment and prevention of viral eye diseases, primarily viral conjunctivitis.

Conclusions: In the complex treatment of patients with adenovirus conjunctivitis, the use of Virostav drug helped to accelerate corneal epithelization. It reduced the treatment time of patients by 4-5 days. The use of Virostav is a safe and effective treatment method for adenovirus conjunctivitis.